These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1087 related articles for article (PubMed ID: 24315327)
21. Risk management frameworks for human health and environmental risks. Jardine C; Hrudey S; Shortreed J; Craig L; Krewski D; Furgal C; McColl S J Toxicol Environ Health B Crit Rev; 2003; 6(6):569-720. PubMed ID: 14698953 [TBL] [Abstract][Full Text] [Related]
22. Cost-Effectiveness Uncertainty Analysis Methods: A Comparison of One-Way Sensitivity, Analysis of Covariance, and Expected Value of Partial Perfect Information. Campbell JD; McQueen RB; Libby AM; Spackman DE; Carlson JJ; Briggs A Med Decis Making; 2015 Jul; 35(5):596-607. PubMed ID: 25349188 [TBL] [Abstract][Full Text] [Related]
23. Expected value of information and decision making in HTA. Eckermann S; Willan AR Health Econ; 2007 Feb; 16(2):195-209. PubMed ID: 16981193 [TBL] [Abstract][Full Text] [Related]
24. Avoiding and identifying errors in health technology assessment models: qualitative study and methodological review. Chilcott J; Tappenden P; Rawdin A; Johnson M; Kaltenthaler E; Paisley S; Papaioannou D; Shippam A Health Technol Assess; 2010 May; 14(25):iii-iv, ix-xii, 1-107. PubMed ID: 20501062 [TBL] [Abstract][Full Text] [Related]
25. Value of information analysis in healthcare: a review of principles and applications. Tuffaha HW; Gordon LG; Scuffham PA J Med Econ; 2014 Jun; 17(6):377-83. PubMed ID: 24650041 [TBL] [Abstract][Full Text] [Related]
26. The value of information for managing contaminated sediments. Bates ME; Sparrevik M; de Lichy N; Linkov I Environ Sci Technol; 2014 Aug; 48(16):9478-85. PubMed ID: 24957130 [TBL] [Abstract][Full Text] [Related]
27. Value of information methods for planning and analyzing clinical studies optimize decision making and research planning. Willan AR; Goeree R; Boutis K J Clin Epidemiol; 2012 Aug; 65(8):870-6. PubMed ID: 22609138 [TBL] [Abstract][Full Text] [Related]
28. Prioritizing Future Research on Allopurinol and Febuxostat for the Management of Gout: Value of Information Analysis. Jutkowitz E; Alarid-Escudero F; Choi HK; Kuntz KM; Jalal H Pharmacoeconomics; 2017 Oct; 35(10):1073-1085. PubMed ID: 28631197 [TBL] [Abstract][Full Text] [Related]
29. Uncertainty in decision-making: value of additional information in the cost-effectiveness of lifestyle intervention in overweight and obese people. Galani C; Al M; Schneider H; Rutten FF Value Health; 2008; 11(3):424-34. PubMed ID: 18179675 [TBL] [Abstract][Full Text] [Related]
30. Use of Value of Information in Healthcare Decision Making: Exploring Multiple Perspectives. Bindels J; Ramaekers B; Ramos IC; Mohseninejad L; Knies S; Grutters J; Postma M; Al M; Feenstra T; Joore M Pharmacoeconomics; 2016 Mar; 34(3):315-22. PubMed ID: 26578403 [TBL] [Abstract][Full Text] [Related]
31. The "e" in cost-effectiveness analyses. A case study of omalizumab efficacy and effectiveness for cost-effectiveness analysis evidence. Campbell JD; McQueen RB; Briggs A Ann Am Thorac Soc; 2014 Feb; 11 Suppl 2():S105-11. PubMed ID: 24559022 [TBL] [Abstract][Full Text] [Related]
32. Decision Criterion and Value of Information Analysis: Optimal Aspirin Dosage for Secondary Prevention of Cardiovascular Events. Basu A; Meltzer D Med Decis Making; 2018 May; 38(4):427-438. PubMed ID: 29529923 [TBL] [Abstract][Full Text] [Related]
33. Cost-effectiveness and value of information analyses of Bruton's tyrosine kinase inhibitors in the treatment of relapsed or refractory mantle cell lymphoma in the United States. Alrawashdh N; McBride A; Slack M; Persky D; Andritsos L; Abraham I J Manag Care Spec Pharm; 2022 Apr; 28(4):390-400. PubMed ID: 35332792 [No Abstract] [Full Text] [Related]
34. Informing a decision framework for when NICE should recommend the use of health technologies only in the context of an appropriately designed programme of evidence development. Claxton K; Palmer S; Longworth L; Bojke L; Griffin S; McKenna C; Soares M; Spackman E; Youn J Health Technol Assess; 2012; 16(46):1-323. PubMed ID: 23177626 [TBL] [Abstract][Full Text] [Related]
35. Using value of information methods to determine the optimal sample size for effectiveness trials of alcohol interventions for HIV-infected patients in East Africa. Li L; Uyei J; Nucifora KA; Kessler J; Stevens ER; Bryant K; Braithwaite RS BMC Health Serv Res; 2018 Jul; 18(1):590. PubMed ID: 30064428 [TBL] [Abstract][Full Text] [Related]
36. [Using value of information analysis in decision making about applied research. The case of genetic screening for hemochromatosis in Germany]. Rogowski WH; Grosse SD; Meyer E; John J; Palmer S Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2012 May; 55(5):700-9. PubMed ID: 22526859 [TBL] [Abstract][Full Text] [Related]
37. Gaussian process metamodeling in Bayesian value of information analysis: a case of the complex health economic model for breast cancer screening. Rojnik K; Naversnik K Value Health; 2008; 11(2):240-50. PubMed ID: 18380636 [TBL] [Abstract][Full Text] [Related]
38. Value of Information Analysis for Research Decisions-An Introduction: Report 1 of the ISPOR Value of Information Analysis Emerging Good Practices Task Force. Fenwick E; Steuten L; Knies S; Ghabri S; Basu A; Murray JF; Koffijberg HE; Strong M; Sanders Schmidler GD; Rothery C Value Health; 2020 Feb; 23(2):139-150. PubMed ID: 32113617 [TBL] [Abstract][Full Text] [Related]
39. Value of information analysis in oncology: the value of evidence and evidence of value. Tuffaha HW; Gordon LG; Scuffham PA J Oncol Pract; 2014 Mar; 10(2):e55-62. PubMed ID: 24194511 [TBL] [Abstract][Full Text] [Related]